Related references
Note: Only part of the references are listed.DREAMseq (Doublet Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial-ECOG-ACRIN EA6134
Michael B. Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Efficacy of BRAF Inhibitors in Combination With Stereotactic Radiosurgery for the Treatment of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis
Muhammad Khan et al.
FRONTIERS IN ONCOLOGY (2021)
Circulating tumor DNA mutation as a prognostic marker in melanoma with brain metastasis.
Tapas Ranjan Behera et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
ctDNA facilitated the diagnosis of a patient with synchronous urothelial carcinoma and non-small cell lung cancer: case report
Chengyuan Qian et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
Gabriella Taques Marczynski et al.
SCIENTIFIC REPORTS (2020)
ctDNA as a cancer biomarker: A broad overview
Luciana Santos Pessoa et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Time to initial cancer treatment in the United States and association with survival over time: An observational study
Alok A. Khorana et al.
PLOS ONE (2019)
Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
Cornelis Bisschop et al.
MELANOMA RESEARCH (2018)
A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day
Arnaud Uguen et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing
Nilesh G. Dharajiya et al.
CLINICAL CHEMISTRY (2018)
Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
Mark R. Openshaw et al.
EBIOMEDICINE (2016)
Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
Georgina V. Long et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Share Paper
